...
首页> 外文期刊>Translational Stroke Research >Biological Features of Human Bone Marrow Stromal Cells (hBMSC) Cultured with Animal Protein-Free Medium—Safety and Efficacy of Clinical Use for Neurotransplantation
【24h】

Biological Features of Human Bone Marrow Stromal Cells (hBMSC) Cultured with Animal Protein-Free Medium—Safety and Efficacy of Clinical Use for Neurotransplantation

机译:无动物蛋白培养基培养的人骨髓基质细胞(hBMSC)的生物学特性—神经移植的临床安全性和有效性

获取原文
获取原文并翻译 | 示例
           

摘要

The donor cell culture in animal serum-free medium is quite important for the clinical application of cell transplantation therapy. This study was aimed to test the hypothesis that the human bone marrow stromal cells (hBMSC) expanded with fetal calf serum (FCS)-free, platelet lysate (PL)-containing medium retain their biological features favoring central nervous system regeneration. The hBMSC were cultured with 5% PL or 10% FCS. Their phenotypes were analyzed with flow cytometry, and their production of growth factors was quantified with enzyme-linked immunosorbent assay. Their capacity of neural differentiation was verified by immunocytochemistry. There was no significant difference in morphology and cell surface marker between the hBMSC–FCS and hBMSC–PL. Both of them were positive for CD44, CD90, CD105, and CD166 and were negative for CD34, CD45, and CD271. The production of human brain-derived neurotrophic factor, human hepatocyte growth factor, human β-nerve growth factor, and human platelet-derived growth factor-BB did not differ between the two groups, although the hBMSC–PL produced significantly more amount of TGF-β1 than the hBMSC–FCS. There was no significant difference in their in vitro differentiation into the neurons and astrocytes between the two groups. The hBMSC expanded with PL-containing medium retain their biological capacity of neural differentiation and neuroprotection. The PL may be a clinically valuable and safe substitute for FCS in expanding the hBMSC for cell therapy.
机译:动物无血清培养基中的供体细胞培养对于细胞移植治疗的临床应用非常重要。这项研究旨在检验以下假设:用不含胎牛血清(FCS)的含血小板裂解物(PL)的培养基扩增的人骨髓基质细胞(hBMSC)保留了有利于中枢神经系统再生的生物学特征。 hBMSC用5%PL或10%FCS培养。用流式细胞仪分析它们的表型,并用酶联免疫吸附测定法定量其生长因子的产生。通过免疫细胞化学证实了它们的神经分化能力。 hBMSC–FCS和hBMSC–PL之间在形态和细胞表面标记上无显着差异。它们都对CD44,CD90,CD105和CD166呈阳性,而对CD34,CD45和CD271呈阴性。两组之间人脑源性神经营养因子,人肝细胞生长因子,人β-神经生长因子和人血小板源性生长因子BB的产生没有差异,尽管hBMSC–PL产生的TGF量明显增加-β1比hBMSC–FCS好。两组在体外分化为神经元和星形胶质细胞方面无显着差异。用含PL培养基扩增的hBMSC保留了其神经分化和神经保护的生物学能力。在扩大hBMSC用于细胞治疗中,PL可能是FCS的临床上有价值且安全的替代品。

著录项

  • 来源
    《Translational Stroke Research》 |2011年第3期|307-315|共9页
  • 作者单位

    Department of Neurosurgery Hokkaido University Graduate School of Medicine North 15 West 7 Kita-ku Sapporo 060-8638 Japan;

    Department of Neurosurgery Hokkaido University Graduate School of Medicine North 15 West 7 Kita-ku Sapporo 060-8638 Japan;

    Department of Neurosurgery Hokkaido University Graduate School of Medicine North 15 West 7 Kita-ku Sapporo 060-8638 Japan;

    Department of Neurosurgery Hokkaido University Graduate School of Medicine North 15 West 7 Kita-ku Sapporo 060-8638 Japan;

    Department of Neurosurgery Hokkaido University Graduate School of Medicine North 15 West 7 Kita-ku Sapporo 060-8638 Japan;

    Department of Medicine II Hokkaido University Graduate School of Medicine Sapporo Japan;

    Department of Medicine II Hokkaido University Graduate School of Medicine Sapporo Japan;

    Department of Medicine II Hokkaido University Graduate School of Medicine Sapporo Japan;

    Department of Neurosurgery Hokkaido University Graduate School of Medicine North 15 West 7 Kita-ku Sapporo 060-8638 Japan;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

    Bone marrow stromal cells; Platelet lysate; Cell culture; Neurotransplantation; Autologous graft; Central nervous system disorders;

    机译:骨髓基质细胞血小板裂解物细胞培养神经移植自体移植中枢神经系统疾病;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号